UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
June 8, 2023
Accession Number:
0001193125-23-163096
Submission Type:
POS AM
CIK:
0001692830
Company Name:
Satsuma Pharmaceuticals, Inc.
File Number:
333-268035